Presenilin 1 (PSEN1) plays a pivotal role in early-onset Alzheimer's disease (EOAD). The clinical phenotype of EOAD is typically marked by cognitive decline, with ataxia rarely reported. We identified mutations at different positions of PSEN1 in two Chinese patients with EOAD. Interestingly, one patient carrying the PSEN1 p.P117L mutation manifested symptoms of ataxia, while another patient harboring the PSEN1 p.P264L mutation did not exhibit any signs of this disorder. Computational analyses using PolyPhen-2, SIFT, Provean, and Mutation Taster predicted both mutations as pathogenic, while structural predictions using SOPMA, TMHMM 2.0, and PyMOL. Our findings expand the spectrum of atypical PSEN1-associated phenotypes.
Hernandez-SapiensMAReza-ZaldivarEEMarquez-AguirreAL, et al.Presenilin mutations and their impact on neuronal differentiation in Alzheimer's disease. Neural Regen Res2022; 17: 31–37.
2.
KurthVOgorekIMunchC, et al.Pathogenic Abeta production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1. J Biol Chem2023; 299: 104997.
3.
LarnerAJDoranM. Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of the presenilin-1 gene. J Neurol2006; 253: 139–158.
4.
JihKYHsuTRFuhJL, et al.Early presentation of spastic paraparesis in individuals carrying PSEN1 mutations: a clinical and genetic analysis. Alzheimers Res Ther2025; 17: 96.
5.
BagariaJBagyinszkyEAnSSA. Genetics, functions, and clinical impact of presenilin-1 (PSEN1) gene. Int J Mol Sci2022; 23: 10970.
TestiSPelusoSFabriziGM, et al.A novel PSEN1 mutation in a patient with sporadic early-onset Alzheimer's disease and prominent cerebellar ataxia. J Alzheimers Dis2014; 41: 709–714.
8.
SeliverstovYKanivetsIIllarioshkinS. Spinocerebellar ataxia-like presentation of the M233V PSEN1 mutation. Cerebellum2020; 19: 744–747.
9.
ZhongXWangQYangM, et al.Plasma p-tau217 and p-tau217/Abeta1-42 are effective biomarkers for identifying CSF- and PET imaging-diagnosed Alzheimer's disease: insights for research and clinical practice. Alzheimers Dement2025; 21: e14536.
10.
DoHNDevkotaSBhattaraiA, et al.Effects of presenilin-1 familial Alzheimer's disease mutations on gamma-secretase activation for cleavage of amyloid precursor protein. Commun Biol2023; 6: 174.
11.
WisniewskiTDowjatWKBuxbaumJD, et al.A novel Polish presenilin-1 mutation (P117L) is associated with familial Alzheimer's disease and leads to death as early as the age of 28 years. Neuroreport1998; 9: 217–221.
12.
RochaALCostaAGarrettMC, et al.Difficult case of a rare form of familial Alzheimer's disease with PSEN1 P117L mutation. BMJ Case Rep2018; 11: e226664.
13.
CollinsRLBrandHKarczewskiKJ, et al.A structural variation reference for medical and population genetics. Nature2020; 581: 444–451.
14.
AnheimMHannequinDBoulayC, et al.Ataxic variant of Alzheimer's disease caused by Pro117Ala PSEN1 mutation. J Neurol Neurosurg Psychiatry2007; 78: 1414–1415.
15.
DowjatWKKuchnaIWisniewskiT, et al.A novel highly pathogenic Alzheimer presenilin-1 mutation in codon 117 (Pro117Ser): comparison of clinical, neuropathological and cell culture phenotypes of Pro117Leu and Pro117Ser mutations. J Alzheimers Dis2004; 6: 31–43.
16.
SimanRReaumeAGSavageMJ, et al.Presenilin-1 P264L knock-in mutation: differential effects on abeta production, amyloid deposition, and neuronal vulnerability. J Neurosci2000; 20: 8717–8726.
17.
MartikainenPPikkarainenMPontynenK, et al.Brain pathology in three subjects from the same pedigree with presenilin-1 (PSEN1) P264L mutation. Neuropathol Appl Neurobiol2010; 36: 41–54.
18.
WolfeMSXiaWOstaszewskiBL, et al.Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature1999; 398: 513–517.
19.
LittauJLVelillaLHaseY, et al.Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease. Brain Pathol2022; 32: e13097.
20.
GhisaysVLoperaFGoradiaDD, et al.PET Evidence of preclinical cerebellar amyloid plaque deposition in autosomal dominant Alzheimer's disease-causing Presenilin-1 E280A mutation carriers. Neuroimage Clin2021; 31: 102749.
21.
XiaMGaoCWangH, et al.Novel PSEN1 (P284S) mutation causes Alzheimer's disease with cerebellar amyloid beta-protein deposition. Curr Alzheimer Res2022; 19: 523–529.
22.
ZhouZZhuRShaoW, et al.Changes in resting-state functional connectivity of cerebellum in amnestic mild cognitive impairment and Alzheimer's disease: a case-control study. Front Syst Neurosci2021; 15: 596221.
23.
RyanNSBiesselsGJKimL, et al.Genetic determinants of white matter hyperintensities and amyloid angiopathy in familial Alzheimer's disease. Neurobiol Aging2015; 36: 3140–3151.
24.
LeeSZimmermanMENarkhedeA, et al.White matter hyperintensities and the mediating role of cerebral amyloid angiopathy in dominantly-inherited Alzheimer's disease. PLoS One2018; 13: e0195838.
25.
Sepulveda-FallaDVillegas LanauCAWhite IiiC, et al.Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: evidence for dependency on Alzheimer disease neuropathological changes. J Neuropathol Exp Neurol2025; 84: 104–113.
26.
DowjatWKWisniewskiHWisniewskiT. Alzheimer's disease presenilin-1 expression modulates the assembly of neurofilaments. Neuroscience2001; 103: 1–8.
27.
CampionDFlamanJMBriceA, et al.Mutations of the presenilin I gene in families with early-onset Alzheimer's disease. Hum Mol Genet1995; 4: 2373–2377.
28.
Al MughramMHCatalanoCHerringtonNB, et al.3D Interaction homology: the hydrophobic residues alanine, isoleucine, leucine, proline and valine play different structural roles in soluble and membrane proteins. Front Mol Biosci2023; 10: 1116868.
29.
LiuLLauroBMWolfeMS, et al.Hydrophilic loop 1 of Presenilin-1 and the APP GxxxG transmembrane motif regulate gamma-secretase function in generating Alzheimer-causing Abeta peptides. J Biol Chem2021; 296: 100393.
30.
KoeppenAH. The pathogenesis of spinocerebellar ataxia. Cerebellum2005; 4: 62–73.
PalmqvistSInselPSStomrudE, et al.Cerebrospinal fluid and plasma biomarker trajectories with increasing amyloid deposition in Alzheimer's disease. EMBO Mol Med2019; 11: e11170.
33.
BrouilletteAMOzGGomezCM. Cerebrospinal fluid biomarkers in spinocerebellar ataxia: a pilot study. Dis Markers2015; 2015: 413098.
34.
GazullaJBellosta-DiagoEIzquierdo-AlvarezS, et al.Spinocerebellar ataxia type 15 caused by missense variants in the ITPR1 gene. Eur J Neurol2023; 30: 2539–2543.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
